UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A genetically-encoded fluorescence-based reporter to spatiotemporally investigate mannose-6-phosphate pathway

Molecular biology of the cell, 2024-08, Vol.35 (8)

2024

Volltextzugriff (PDF)

Hilbert series for covariants and their applications to minimal flavor violation

The journal of high energy physics, 2024-06, Vol.2024 (6), p.154-83, Article 154

2024

Volltextzugriff (PDF)

Come Together: Bridge RNAs Close the Gap to Genome Design

GEN Biotechnology, 2024-08, Vol.3 (4), p.178-182

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

Where Are the Cell Therapies for Type 1 Diabetes?: Despite 100 years of research, type 1 diabetes is still uncured, but donor- and stem cell-derived allogeneic pancreatic islets may be the answer but are hampered by regulatory resistance

Inside Precision Medicine, 2024-08, Vol.11 (4), p.30-33

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

ALP contribution to the strong C P problem

Physical review. D, 2024-07, Vol.110 (1), Article 015024

2024

Volltextzugriff (PDF)

When Needs Don’t Translate into Wants: Choosing the Right Tone to Communicate About Healthy Behaviors

Health communication, 2024-07, p.1-12

2024

Volltextzugriff (PDF)

Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on preoperative and postoperative assessment and management

The Journal of heart and lung transplantation, 2024-07

2024

Volltextzugriff (PDF)

PO-CES-01 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2

Heart rhythm, 2024-05, Vol.21 (5), p.S721-S721

2024

Volltextzugriff (PDF)

MP-470543-003 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2

Heart rhythm, 2024-05, Vol.21 (5), p.S53-S54

2024

Volltextzugriff (PDF)

Tick-Borne Relapsing Fever Infection from a Bunker, a Case Report on a “One Health” Approach

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2024-07

2024

Volltextzugriff (PDF)

Making the Case: Exploring the Role of Case Management in Relocation and Return Decisions in Choice Neighborhoods Initiative

City & community, 2024-07

2024

Volltextzugriff (PDF)

Abstract 12407: A Comparison of Hemodynamic and Cardiopulmonary Exercise Stress Variables for Advanced Heart Failure Prognosis

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

The Ethical Line Connecting Hieroglyphics to Hyperlinks

International Journal of Civilizations Studies & Tolerance Sciences, 2024-05, Vol.1 (1), p.28-31

Grinstein, Gidi

2024

Volltextzugriff (PDF)

What do I think about this sustainable Gucci? Product- or company-focused sustainability association, impact on environment, and attractiveness of luxury products

Advances in Consumer Research, 2022, Vol.50, p.276-277

2022

Volltextzugriff (PDF)

Mind the Gap: Advice Givers and Receivers in Well-Being Communication

Advances in Consumer Research, 2019, Vol.47, p.713-714

2019

Volltextzugriff (PDF)

Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes

ASAIO journal (1992), 2024-08

2024

Volltextzugriff (PDF)

Does Sparing the Rod Spoil the Child? How Praising, Scolding, and Assertive Tone can Encourage Pro-Social Behavior

Advances in Consumer Research, 2015, Vol.43, p.599-600

2015

Volltextzugriff (PDF)

Blood Brothers: Kyverna Reinvents Autologous CAR T Manufacturing from Blood Draw: Ingenui-T utilizes whole blood from a standard blood draw, offering a less-invasive alternative to apheresis as well as substantial reduction of cost

GEN edge, 2024-01, Vol.6 (1), p.65-72

Grinstein, Jonathan D

2024

Volltextzugriff (PDF)

AACR 2024: Geneos Therapeutics' Vaccine Outperforms Liver Cancer Immunotherapies: CEO and president Niranjan Sardesai details how the DNA-based personalized therapeutic vaccines were designed to capture tumor heterogeneity to improve outcomes for hepatocellular carcinoma patients

GEN edge, 2024-01, Vol.6 (1), p.345-349

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

Earli Detection: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers: Backed by Bob Langer, Jim Allison, Lee Hartwell, and a who's who roster of the cancer world, the California startup is taking the late Sanjiv (Sam) Gambhir's cancer detection technology from concept to the clinic

GEN edge, 2024-01, Vol.6 (1), p.364-368

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

Ultragenyx's Gene Therapy Ameliorates Pediatric Neurodegenerative Disorder: Sanfilippo syndrome type A (MPS IIIA) patients treated with UX111 showed sustained reductions in heparan sulfate in their cerebrospinal fluid and improved long-term cognitive development

GEN edge, 2024-01, Vol.6 (1), p.118-121

Grinstein, Jonathan D

2024

Volltextzugriff (PDF)

ASGCT 2024: SalioGen's Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides: The data shows that lipid nanoparticle delivery of bioengineered mammalian transposases can integrate large genes at precise locations and is being developed into one-time treatments for Stargardt disease and cystic fibrosis

GEN edge, 2024-01, Vol.6 (1), p.459-463

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

On the Lookout: Prometheus Veterans Launch Mirador Therapeutics With $400 Million: The vision to bring precision medicine to immunology and inflammation brought on a financing avalanche led by ARCH Venture Partners, OrbiMed, Fairmount, and other premier life sciences investors

GEN edge, 2024-01, Vol.6 (1), p.255-258

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines: The multi-year collaboration allows GSK to leverage Elegen's cell-free synthetic DNA production technology

GEN edge, 2024-01, Vol.6 (1), p.65-68

Grinstein, Jonathan D

2024

Volltextzugriff (PDF)

Come Together: Bridge RNAs Close the Gap to Genome Design: Buried in a family of mobile genetic elements, Arc Institute researchers led by Patrick Hsu, PhD, have discovered an RNA-guided system that enables modular and programmable DNA insertions, excisions, and inversions—another sizeable step for programmable genome engineering

GEN edge, 2024-01, Vol.6 (1), p.570-581

Grinstein, Jonathan D.

2024

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(15)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Consumer Behavior
(6)
Communication
(5)
Science & Technology
(5)
Life Sciences & Biomedicine
(4)
Social Sciences
(3)
Management
(2)
Advertising Campaigns
(1)
Aesthetics
(1)
Aortic Insufficiency
(1)
Aortic Valve Replacement
(1)
Biotechnology & Applied Microbiology
(1)
Business
(1)
Business & Economics
(1)
Business Communications
(1)
Cell Biology
(1)
Classical And Quantum Gravitation
(1)
Consumption
(1)
Eating Behavior
(1)
Eating Disorders
(1)
Effective Field Theories
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gen Edge
(23)
Genetic Engineering & Biotechnology News
(4)
Heart Rhythm
(2)
Scientific American
(2)
Asaio Journal
(1)
Circulation
(1)
City & Community
(1)
Gen Biotechnology
(1)
Health Communication
(1)
Inside Precision Medicine
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A genetically-encoded fluorescence-based reporter to spatiotemporally investigate mannose-6-phosphate pathway

Hilbert series for covariants and their applications to minimal flavor violation

Come Together: Bridge RNAs Close the Gap to Genome Design

Where Are the Cell Therapies for Type 1 Diabetes?: Despite 100 years of research, type 1 diabetes is still uncured, but donor- and stem cell-derived allogeneic pancreatic islets may be the answer but are hampered by regulatory resistance

ALP contribution to the strong C P problem

When Needs Don’t Translate into Wants: Choosing the Right Tone to Communicate About Healthy Behaviors

Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on preoperative and postoperative assessment and management

PO-CES-01 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2

MP-470543-003 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2

Tick-Borne Relapsing Fever Infection from a Bunker, a Case Report on a “One Health” Approach

Making the Case: Exploring the Role of Case Management in Relocation and Return Decisions in Choice Neighborhoods Initiative

Abstract 12407: A Comparison of Hemodynamic and Cardiopulmonary Exercise Stress Variables for Advanced Heart Failure Prognosis

The Ethical Line Connecting Hieroglyphics to Hyperlinks

What do I think about this sustainable Gucci? Product- or company-focused sustainability association, impact on environment, and attractiveness of luxury products

Mind the Gap: Advice Givers and Receivers in Well-Being Communication

Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes

Does Sparing the Rod Spoil the Child? How Praising, Scolding, and Assertive Tone can Encourage Pro-Social Behavior

Blood Brothers: Kyverna Reinvents Autologous CAR T Manufacturing from Blood Draw: Ingenui-T utilizes whole blood from a standard blood draw, offering a less-invasive alternative to apheresis as well as substantial reduction of cost

AACR 2024: Geneos Therapeutics' Vaccine Outperforms Liver Cancer Immunotherapies: CEO and president Niranjan Sardesai details how the DNA-based personalized therapeutic vaccines were designed to capture tumor heterogeneity to improve outcomes for hepatocellular carcinoma patients

Earli Detection: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers: Backed by Bob Langer, Jim Allison, Lee Hartwell, and a who's who roster of the cancer world, the California startup is taking the late Sanjiv (Sam) Gambhir's cancer detection technology from concept to the clinic

Ultragenyx's Gene Therapy Ameliorates Pediatric Neurodegenerative Disorder: Sanfilippo syndrome type A (MPS IIIA) patients treated with UX111 showed sustained reductions in heparan sulfate in their cerebrospinal fluid and improved long-term cognitive development

On the Lookout: Prometheus Veterans Launch Mirador Therapeutics With $400 Million: The vision to bring precision medicine to immunology and inflammation brought on a financing avalanche led by ARCH Venture Partners, OrbiMed, Fairmount, and other premier life sciences investors

GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines: The multi-year collaboration allows GSK to leverage Elegen's cell-free synthetic DNA production technology

Aktive Filter

Suchergebnisse filtern